College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
Pti
1. Dr. SACHIN SONI
DNB PEDIATRICS
Indraprastha Apollo Hospital
New Delhi
www.dnbpediatrics.com
2.
Tuberculosis is caused by Mycobacterium tuberculosis
(M. bovis and M. africanum)
Its mainly affect the lung peranchyma but can affect
other organs as well
Children are more likely develop extrapulmonary and
severe disseminated disease as compared to adult
www.dnbpediatrics.com
3. Its one of the most widespread infections affecting
almost one third of the worlds population
Globally about 1 million cases of pediatric TB are
estimated to occur every year accounting for 10-15% of
all TB cases
In INDIA:
1990 1995 2000 2005 2011
www.dnbpediatrics.com
4. Number (Millions)
Rate Per 100,000
Persons
2.0 (1.6-2.4)
168
AFB positive
1.7 (1.3-2.1)
165 (126-204)
Prevalence, all cases
(2009 WHO
estimate)
3.0 (1.3-5.0)
249
Incidence
All cases (2009
WHO estimate)
Period Prevalence
(2000 estimate)
www.dnbpediatrics.com
6. The presence of three or more of the following should
strongly suggest a diagnosis of TB:
- Chronic symptoms suggestive of TB
- Physical signs highly of suggestive of TB
- A positive tuberculin skin test
- Chest X-ray suggestive of TB
www.dnbpediatrics.com
12. All efforts should be made to demonstrate
bacteriological evidence for diagnosis
In cases sputum is not available, alternative specimens:-Gastric lavage
-Induced sputum
-Broncho-alveolar lavage
www.dnbpediatrics.com
13. 2010
2012
Unexplained recent loss
of weight pointer to
suspicion of TB
Static weight /not
growing well are not
significant pointer
toward diagonsis
www.dnbpediatrics.com
Loss of weight – used
as a clinical marker for
disease defined as a loss
of more than 5% of the
highest weight recorded
in the past three months
14. 2010
Positive Tuberculin skin
test/Mantoux test:An induration of 10 mm
with Tuberculin 1 TU
(RT 23)
If patient return for
reading beyond 72 h but
by 7th day positive test
can still be read
www.dnbpediatrics.com
2012
Positive Tuberculin skin
test/Mantoux test:- An
induration of 10 mm or
more, measured 48-72
hours after Intradermal
injection with
Tuberculin 2 TU (RT 23
or equivalent) and
No more than 5TU
(RT23 or equivalent)
should be used
15.
No role for inaccurate/inconsistent diagnostics test like
serology - IgM, IgG, IgA antibodies against MTB
antigens, non validated commercial PCR tests and
BCG test
No role of IGRAs in clinical practice for
diagnosis of TB
Lymph Node TB suspect definitions revisited and
greater clarity and updated guidance
www.dnbpediatrics.com
17. New case: Who has had no previous ATT or had it for
less then 2 week duration
Failure to respond: Who fails to have bacteriological
conversion to negative status or fails to respond
clinically/or deteriorates after 12 weeks of compliant
intensive phase
Relapse: A case of TB declared cured/completed
therapy in past and has (clinical or bacteriological)
evidence of recurrence
Treatment after default: Who has taken treatment for at
least 4 weeks and comes after interruption of treatment
for 2 months or more and has active disease (clinical or
bacteriological
www.dnbpediatrics.com
18. TB chemotherapy should be based on two
important microbiological considerations:
1.
The combination of drugs to avoid the
development of resistance.
2.
The need for prolonged chemotherapy to
prevent disease relapse
www.dnbpediatrics.com
19.
All mono-therapeutic regimens (real or masked by
combination with drugs to which bacilli are resistant)
lead to treatment failure and to the development of
resistance.
When three or more drugs are administered, the risk of
resistance is practically very low.
www.dnbpediatrics.com
20. 2012
2010
The intermittent therapy
remain the mainstay of
treatment
Seriously ill admitted
children or severe
disseminated disease/
neurotuberculosis, vomiting
or non-tolerance of oral drugs
is high in the initial phase
Such, patients can be given
daily supervised therapy
during their hospital stay
After discharge they will be
taken on thrice weekly DOT
regimen
www.dnbpediatrics.com
Tubecular bacilli exposed to
certain concentration of most
currently used ATT shows
inhibition of growth for 1 to
several days
Intermittent thrice weekly
therapy with higher dose is as
effective as alternative
21. New six weight bands (6-8,9-12,13-16,17-20,2124,and 25-30 kg) was created and keep them
sufficiently narrow to avoid large fluctuations at the
ends of the weight band
Attempt to create generic boxes for each of the weight
band instead of current practice of having combine
boxes which significantly increases pill burden in
children of >18kgs
www.dnbpediatrics.com
25. Strongly recommended using dispersible tablet
formulations under the RNTCP programme
DOT centers will be provided with pestle and mortars
for crushing the drugs
It will be responsibility of DOT provider to supervise
process of drug consumption
Any child vomits within half an hour of period of
observation, fresh dosages for all drugs vomited will be
provided to the caregiver
www.dnbpediatrics.com
26. Cat III regimen: Though, there is utility of Cat III
regimen in some pediatric TB cases
In evidence of relatively high INH resistance i(>5%
cases) And
Increasing evidence of safety of Ethambutol in the
doses used under RNTCP, Cat III need not be revisited
Only two treatment categories –
Cat 1- New cases
Cat 2- Previously treated cases
www.dnbpediatrics.com
29. Streptomycin can be safely replaced by ethambutol in
intensive phase of TBM because:1- Current evidence favoring safety and efficacy of
Ethambutol
2- Lack of any value addition in efficacy using
Streptomycin over ethambutol
3- Need to avoid problems of injection based treatment
(lack of adequate muscle mass in malnourished, risks of
unsafe Injections, need for a trained personnel,
unpleasantness of the treatment).
While ethambutol was considered a better option to
replace streptomycin in the treatment of new cases
Streptomycin continues to be recommended as the
additional fifth drug in the retreatment
www.dnbpediatrics.com
30. Inadequate or no response (on smear or clinicoradiological basis) at 8 weeks of intensive phase should
be given extension of IP for one more month
In patients with TB Meningitis, spinal TB, miliary/
disseminated TB and osteo-articular TB, continuation
phase shall be extended by 3 months making the total
duration of treatment of 9 months
A further extension may be done for 3 more months in
continuation phase (making the total duration of
treatment to 12 months) on a case to case basis in case
of delayed response
www.dnbpediatrics.com
31.
RNTCP may explore and pilot test the feasibility and
effectiveness of alternate approaches like “Mother or
caregiver at home as DOT provider” in selected areas
www.dnbpediatrics.com
32.
Currently Recommended dose of INH for chemoprophylaxis is
10 mg/kg (instead of currently recommended dosage of 5 mg/kg)
administered daily for 6 months to:All asymptomatic contacts (under 6 years of age) of smear
positive case, after ruling out active disease and irrespective of
their BCG, TST or nutritional status.
All HIV infected children who either had a known exposure to
infectious TB case or are Tuberculin skin test (TST) positive (>=5
mm induration) but have no active TB disease
All TST positive children who are receiving immunosuppressive
therapy:Nephrotic syndrome, acute leukemia
Child born to mother who was diagnosed to have TB in pregnancy
should receive prophylaxis for 6 months
BCG vaccination can be given at birth even if INH
chemoprophylaxis is planned
www.dnbpediatrics.com